Menu Close

AbbVie Inc.

AbbVie Inc.

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

AbbVie’s mission is to discover and deliver innovative medicines and solutions that address complex health issues and enhance people's lives.

It also developed Skyrizi ($5 billion in 2022 revenues), an interleukin-23 (IL-23) inhibitor also used to treat autoimmune diseases. Its other major products include Botox ($5 billion in 2022 revenues), Imbruvica to treat cancer ($4.5 billion in 2022 revenues), Rinvoq to treat arthritis ($2.5 billion in 2022 revenues), Venclexta to treat leukemia and lymphoma ($2 billion in annual revenues), Vraylar to treat schizophrenia and bipolar disorder ($2 billion in 2022 revenues), and Mavyret to treat Hepatitis C ($1.5 billion in 2022 revenues). The company is also committed to product development for other treatments of cancer, neurologic diseases, eye care, and cystic fibrosis.

Our products are approved in individual countries for specific uses and the information provided is governed by local regulations. Product availability, name and indicated use may vary by country. Please contact your local AbbVie office to learn more about products available in your country.

Not all products may be listed. This list may be updated at any time. Always ask a healthcare professional for advice about medicines.

All product names are trademarks owned by or licensed to AbbVie Inc. or its subsidiaries.

Medical Information Requests:

If you are a healthcare professional or a patient or caregiver and would like to search for product information or submit an inquiry to the AbbVie Medical Information team, visit

Powered by 50,000 employees across the globe, it is the responsibility and the privilege of everyone at AbbVie to support our communities, better our society and help the patients of today and tomorrow.

Drugs Associated with AbbVie Inc.

AbbVie Inc. manufactures, markets and/or distributes more than 120 drugs in the United States. Medications listed here may also be marketed under different names in different countries.


AbbVie Inc.
1 North Waukegan Road
North Chicago, IL 60064
Phone: 1-800-255-5162
ZIP Code

Leave a Reply

Please leave correct email if you want us to contact you

Your email address will not be published. Required fields are marked *